STOCK TITAN

RNAC (NASDAQ: RNAC) insider plans Rule 144 sale of 9,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of RNAC, identified as Christopher M. Jewell, filed a Rule 144 notice to sell 9,000 shares of common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value listed as $68,940.00 and total shares outstanding shown as 26,003,606. The shares to be sold were acquired on 01/10/2025 by exercising options under a registered plan for cash. Over the prior three months, the same seller reported additional common stock sales of 17,935 shares on 11/19/2025 for $129,587.55 and 10,510 shares on 01/09/2026 for $84,256.57, indicating ongoing liquidation of a portion of their position.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many RNAC shares is Christopher M. Jewell planning to sell under this Rule 144 filing?

The notice states that Christopher M. Jewell intends to sell 9,000 shares of RNAC common stock under Rule 144.

What is the aggregate market value of the RNAC shares to be sold?

The filing lists an aggregate market value of $68,940.00 for the 9,000 common shares proposed to be sold.

How and when were the RNAC shares being sold acquired?

The 9,000 shares were acquired on 01/10/2025 through the exercise of options under a registered plan, with the payment described as cash.

Which broker and exchange are involved in this RNAC Rule 144 sale?

The sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, and the common stock is listed for sale on the NASDAQ exchange.

How many RNAC shares has Christopher M. Jewell sold in the past three months?

Over the past three months, the notice reports sales of 17,935 common shares on 11/19/2025 for $129,587.55 and 10,510 common shares on 01/09/2026 for $84,256.57.

What is the total number of RNAC common shares outstanding referenced in the filing?

The document cites 26,003,606 RNAC common shares outstanding as a baseline figure for the issuer's capital structure.

Cartesian

NASDAQ:RNAC

RNAC Rankings

RNAC Latest News

RNAC Latest SEC Filings

RNAC Stock Data

191.39M
10.39M
59.85%
25.41%
9.09%
Biotechnology
Pharmaceutical Preparations
Link
United States
FREDERICK